HICCC Director Anil Rustgi, MD, is being honored for his major contributions in advancing the care of patients with digestive diseases through clinical or translational research.
Dr. Gulam Manji presented results from a phase II clinical trial testing a combination therapy for resectable gastric cancer or gastroesophageal junction (GEJ) cancer at this year’s AACR conference.
Congratulations to Dr. Joel Gabre, recipient of a 2022 Research Scholar Award from the American Gastroenterological Association (AGA) Research Foundation.
Congratulations to Ricardo Cruz-Acuña, PhD, recent recipient of the Charles H. Revson Senior Fellowship in Biomedical Science to support his work in esophageal adenocarcinoma.
In a new study by Adam Bass, MD, scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.